GTSI Corp. (Nasdaq:GTSI) a systems integrator, solutions and services provider to the U.S. Federal, state and local governments, announced that the Board of Directors has appointed Sterling E. Phillips, Jr. as GTSI’s new Chief Executive Officer and President.
“After an extensive search the Board has selected Sterling Phillips to lead GTSI. Sterling is a proven leader with a track record of growth in the government contracting industry,” said John Toups, Chairman of GTSI’s Board of Directors. “For nearly three decades GTSI has been focused on innovative technology solutions and services to its government customers.
Having a seasoned leader like Sterling at the helm will enable GTSI to continue to focus on management’s strategic plan to grow GTSI’s core business while expanding professional services and investing in solutions development with the goal of increasing shareholder value.”
GTSI Corp. engages in selling information technology (NYSE:IT) products and solutions to departments and agencies of the U.S. federal government, as well as to state and local governments, and prime contractors.
Crown Equity Holdings Inc. (OTCBB:CRWE.OB) reported its financial results for the nine month period ending September 30, 2010.
Revenue for the nine months totaled $1,073,383 compared to $418,959 during 2009.
With the World Wide Web, you can distribute various announcements to millions of users in a timely manner.
Because there is virtually no time lag from the time it takes to publish information to making the information available to users, the Web is an ideal medium to publicize announcements.
As more people discover the virtues of the Web and get connected to the Internet, the Web will become the medium of choice for many organizations and individuals to publicize various announcements.
The Company incurred an operating loss of $54,527 for the nine months ending September 30, 2010 compared to an operating loss of $36,923 during the same period in 2009.
In this case, Kenneth Bosket, President and CEO of Crown Equity Holdings Inc, commented: “Our continued progress in operations including an operating profit of $7,251 during the last quarter shows a continued growth in our business. Not only do our financial results show strong growth during this year but our continued investment in infrastructure will support our future growth.”
More about CRWE at: www.crownequityholdings.com
Guaranty Federal Bancshares Inc. (Nasdaq:GFED) announced that Brad Farris has joined Guaranty Bank's Mortgage Center as a Residential Lender.
Farris comes to Guaranty Bank from Farris Mortgage, a mortgage company he started in 1993. In his new position with the bank, Farris is responsible for business development and customer service related to the bank's full line of mortgage loan products in southwest Missouri.
"This is a fantastic partnership," says McFatridge. "Guaranty Bank has been assisting customers with home ownership in this area since 1913. We have a great team of people and adding someone of Brad's caliber and experience who has such a passion for the business will continue to set our mortgage services apart."
Guaranty Federal Bancshares, Inc. operates as the holding company for Guaranty Federal Savings Bank that provides banking services in Greene and Christian Counties in southwest Missouri.
Harvard Bioscience Inc. (Nasdaq:HBIO) a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science and regenerative medicine, has filed two major patents in the field of regenerative medicine, the first covering 61 claims for its stem cell therapy injectors and the second for 338 claims for bioreactors for organ growth.
David Green, President of Harvard Bioscience, commented, "This is an important milestone for Harvard Bioscience illustrating the value we place on our intellectual property in the emerging field of regenerative medicine. Our strategy is to supply tools to researchers and clinicians within the field of regenerative medicine, and completing these patent filings marks an important milestone in that plan."
Harvard Bioscience, Inc. develops, manufactures, and markets apparatus and scientific instruments used in life science research in pharmaceutical and biotechnology companies, universities, and government laboratories in the United States and internationally.
Sign-Up For Free Stock Alerts At http://crwepicks.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.The CRWEPicks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer ( http://crwepicks.com/disclaimer ) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEPicks.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. ( read more ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.